科室开展特色手术:(1)晚期卵巢癌的肿瘤细胞减灭术,2023年10月在欧洲肿瘤内科学会(ESMO)年会上发表了题为"Pamiparib combined with surufatinib as a neoadjuvant therapy for advanced ovarian cancer patients in the entire population: Preliminary results of a prospective, exploratory, single-arm phase II clinical study"的壁报。安徽省抗癌协会肿瘤内分泌专业委员会主任委员,二等奖。进修学习等,